Literature DB >> 1994054

Viability of cancer clinical research: patient accrual, coverage, and reimbursement. American Medical Association Council on Scientific Affairs.

.   

Abstract

Entities:  

Mesh:

Year:  1991        PMID: 1994054     DOI: 10.1093/jnci/83.4.254

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

1.  Temporal Trends and Predictors for Cancer Clinical Trial Availability for Medically Underserved Populations.

Authors:  David E Gerber; Ashley M Lakoduk; Laurin L Priddy; Jingsheng Yan; Xian-Jin Xie
Journal:  Oncologist       Date:  2015-05-27

2.  Consent timing and experience: modifiable factors that may influence interest in clinical research.

Authors:  David E Gerber; Drew W Rasco; Celette Sugg Skinner; Jonathan E Dowell; Jingsheng Yan; Jennifer R Sayne; Yang Xie
Journal:  J Oncol Pract       Date:  2011-12-06       Impact factor: 3.840

3.  QTc Interval-Prolonging Medications Among Patients With Lung Cancer: Implications for Clinical Trial Eligibility and Clinical Care.

Authors:  Tri Le; Hui Yang; Sawsan Rashdan; Mark S Link; Vlad G Zaha; Carlos Alvarez; David E Gerber
Journal:  Clin Lung Cancer       Date:  2019-11-25       Impact factor: 4.785

4.  What constitutes a "clinical trial"?: a survey of oncology professionals.

Authors:  James R Wright; Brenda Kowaleski; Jonathan Sussman
Journal:  Trials       Date:  2008-03-03       Impact factor: 2.279

5.  Barriers and facilitators for clinical trial participation among diverse Asian patients with breast cancer: a qualitative study.

Authors:  Guek Eng Lee; Mandy Ow; Desiree Lie; Rebecca Dent
Journal:  BMC Womens Health       Date:  2016-07-22       Impact factor: 2.809

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.